Literature DB >> 1982344

The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function.

V Leviel1, A Gobert, B Guibert.   

Abstract

A push-pull cannula supplied with an artificial cerebrospinal fluid containing the tritiated precursor of dopamine, [3H]tyrosine, was implanted in the caudate nucleus of rats anesthetized with halothane. The extracellular dopamine and dihydroxyphenylacetic acid were measured in successive 20 min fractions (both in their tritiated and unlabeled form) and the ratio between the two forms calculated. Glutamate was added to the superfusing cerebrospinal fluid to investigate its role in the process of dopamine release. The release of dopamine and the efflux of dihydroxyphenylacetic acid were activated by a low concentration (10(-8) M) of glutamate. In contrast, a higher concentration (10(-4) M) of the amino acid reduced the release of dopamine. These results first confirmed the presence of a dual mechanism of control, by glutamate, of the dopamine release in the striatum depending on the extracellular concentration. Secondly, these treatments affected the dihydroxyphenylacetic acid amount and predominantly the tritiated form of dopamine, suggesting that the glutamate induces an important increase of the amine synthesis, in spite of a moderate effect on the release. The reversal of the inhibition by applications of tetrodotoxin (5 x 10(-7) M) and bicuculline (10(-4) M) confirmed that it was mediated by an indirect mechanism involving a GABAergic neurotransmission. In addition, the increase of the spontaneous dopamine release during bicuculline application suggested the existence of a tonic mechanism of inhibition of dopamine release in the striatum. This was confirmed by the fact that local xylocaine-induced anesthesia of the sensory motor cortex increased the spontaneous release of dopamine in the striatum.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982344     DOI: 10.1016/0306-4522(90)90269-a

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors:  D C Hoffman
Journal:  J Neural Transm Gen Sect       Date:  1992

3.  Modulation of [3H]dopamine release by glutathione in mouse striatal slices.

Authors:  Réka Janáky; Róbert Dohovics; Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

4.  Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study.

Authors:  Antonio P Strafella; Ji Hyun Ko; Joshua Grant; Maria Fraraccio; Oury Monchi
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

Review 5.  The effects of stress on central dopaminergic neurons: possible clinical implications.

Authors:  J M Finlay; M J Zigmond
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

6.  Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats.

Authors:  H Toyoda; R Takahata; Y Inayama; J Sakai; H Matsumura; H Yoneda; H Asaba; T Sakai
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

7.  The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

Authors:  D C Hoffman; H Donovan; J V Cassella
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

Authors:  L H Burns; B J Everitt; A E Kelley; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

9.  Correlation of 3-mercaptopropionic acid induced seizures and changes in striatal neurotransmitters monitored by microdialysis.

Authors:  Eric W Crick; Ivan Osorio; Mark Frei; Andrew P Mayer; Craig E Lunte
Journal:  Eur J Pharm Sci       Date:  2014-01-22       Impact factor: 4.384

10.  The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat.

Authors:  B H Westerink; M Santiago; J B De Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.